VisEn Medical Inc., a Woburn, Mass.-based developer of fluorescence molecular imaging technology platforms, has raised around $7.5 million in Series B funding, according to a regulatory filing. Merck Capital Ventures was joined by return backers Flagship Ventures, Siemens AG Medical Solutions and Spinnaker Capital.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.